Cargando…

Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants

BACKGROUND: Natural products are well recognized as sources of drugs in several human ailments. In the present work, we carried out a preliminary screening of six natural compounds, xanthone V(1) (1); 2-acetylfuro-1,4-naphthoquinone (2); physcion (3); bisvismiaquinone (4); vismiaquinone (5); 1,8-dih...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuete, Victor, Wabo, Hippolyte K., Eyong, Kenneth O., Feussi, Michel T., Wiench, Benjamin, Krusche, Benjamin, Tane, Pierre, Folefoc, Gabriel N., Efferth, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158745/
https://www.ncbi.nlm.nih.gov/pubmed/21886765
http://dx.doi.org/10.1371/journal.pone.0021762
_version_ 1782210388605009920
author Kuete, Victor
Wabo, Hippolyte K.
Eyong, Kenneth O.
Feussi, Michel T.
Wiench, Benjamin
Krusche, Benjamin
Tane, Pierre
Folefoc, Gabriel N.
Efferth, Thomas
author_facet Kuete, Victor
Wabo, Hippolyte K.
Eyong, Kenneth O.
Feussi, Michel T.
Wiench, Benjamin
Krusche, Benjamin
Tane, Pierre
Folefoc, Gabriel N.
Efferth, Thomas
author_sort Kuete, Victor
collection PubMed
description BACKGROUND: Natural products are well recognized as sources of drugs in several human ailments. In the present work, we carried out a preliminary screening of six natural compounds, xanthone V(1) (1); 2-acetylfuro-1,4-naphthoquinone (2); physcion (3); bisvismiaquinone (4); vismiaquinone (5); 1,8-dihydroxy-3-geranyloxy-6-methylanthraquinone (6) against MiaPaCa-2 pancreatic and CCRF-CEM leukemia cells and their multidrug-resistant subline, CEM/ADR5000. Compounds 1 and 2 were then tested in several other cancer cells and their possible mode of action were investigated. METHODOLOGY/FINDINGS: The tested compounds were previously isolated from the Cameroonian medicinal plants Vismia laurentii (1, 3, 4, 5 and 6) and Newbouldia laevis (2). The preliminary cytotoxicity results allowed the selection of xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, which were then tested on a panel of cancer cell lines. The study was also extended to the analysis of cell cycle distribution, apoptosis induction, caspase 3/7 activation and the anti-angiogenic properties of xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone. IC(50) values around or below 4 µg/ml were obtained on 64.29% and 78.57% of the tested cancer cell lines for xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, respectively. The most sensitive cell lines (IC(50)<1 µg/ml) were breast MCF-7 (to xanthone V(1)), cervix HeLa and Caski (to xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone), leukemia PF-382 and melanoma colo-38 (to 2-acetylfuro-1,4-naphthoquinone). The two compounds showed respectively, 65.8% and 59.6% inhibition of the growth of blood capillaries on the chorioallantoic membrane of quail eggs in the anti-angiogenic assay. Upon treatment with two fold IC(50) and after 72 h, the two compounds induced cell cycle arrest in S-phase, and also significant apoptosis in CCRF-CEM leukemia cells. Caspase 3/7 was activated by xanthone V(1). CONCLUSIONS/SIGNIFICANCE: The overall results of the present study provided evidence for the cytotoxicity of compounds xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, and bring supportive data for future investigations that will lead to their use in cancer therapy.
format Online
Article
Text
id pubmed-3158745
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31587452011-08-30 Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants Kuete, Victor Wabo, Hippolyte K. Eyong, Kenneth O. Feussi, Michel T. Wiench, Benjamin Krusche, Benjamin Tane, Pierre Folefoc, Gabriel N. Efferth, Thomas PLoS One Research Article BACKGROUND: Natural products are well recognized as sources of drugs in several human ailments. In the present work, we carried out a preliminary screening of six natural compounds, xanthone V(1) (1); 2-acetylfuro-1,4-naphthoquinone (2); physcion (3); bisvismiaquinone (4); vismiaquinone (5); 1,8-dihydroxy-3-geranyloxy-6-methylanthraquinone (6) against MiaPaCa-2 pancreatic and CCRF-CEM leukemia cells and their multidrug-resistant subline, CEM/ADR5000. Compounds 1 and 2 were then tested in several other cancer cells and their possible mode of action were investigated. METHODOLOGY/FINDINGS: The tested compounds were previously isolated from the Cameroonian medicinal plants Vismia laurentii (1, 3, 4, 5 and 6) and Newbouldia laevis (2). The preliminary cytotoxicity results allowed the selection of xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, which were then tested on a panel of cancer cell lines. The study was also extended to the analysis of cell cycle distribution, apoptosis induction, caspase 3/7 activation and the anti-angiogenic properties of xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone. IC(50) values around or below 4 µg/ml were obtained on 64.29% and 78.57% of the tested cancer cell lines for xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, respectively. The most sensitive cell lines (IC(50)<1 µg/ml) were breast MCF-7 (to xanthone V(1)), cervix HeLa and Caski (to xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone), leukemia PF-382 and melanoma colo-38 (to 2-acetylfuro-1,4-naphthoquinone). The two compounds showed respectively, 65.8% and 59.6% inhibition of the growth of blood capillaries on the chorioallantoic membrane of quail eggs in the anti-angiogenic assay. Upon treatment with two fold IC(50) and after 72 h, the two compounds induced cell cycle arrest in S-phase, and also significant apoptosis in CCRF-CEM leukemia cells. Caspase 3/7 was activated by xanthone V(1). CONCLUSIONS/SIGNIFICANCE: The overall results of the present study provided evidence for the cytotoxicity of compounds xanthone V(1) and 2-acetylfuro-1,4-naphthoquinone, and bring supportive data for future investigations that will lead to their use in cancer therapy. Public Library of Science 2011-08-19 /pmc/articles/PMC3158745/ /pubmed/21886765 http://dx.doi.org/10.1371/journal.pone.0021762 Text en Kuete et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kuete, Victor
Wabo, Hippolyte K.
Eyong, Kenneth O.
Feussi, Michel T.
Wiench, Benjamin
Krusche, Benjamin
Tane, Pierre
Folefoc, Gabriel N.
Efferth, Thomas
Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants
title Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants
title_full Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants
title_fullStr Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants
title_full_unstemmed Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants
title_short Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants
title_sort anticancer activities of six selected natural compounds of some cameroonian medicinal plants
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158745/
https://www.ncbi.nlm.nih.gov/pubmed/21886765
http://dx.doi.org/10.1371/journal.pone.0021762
work_keys_str_mv AT kuetevictor anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants
AT wabohippolytek anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants
AT eyongkennetho anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants
AT feussimichelt anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants
AT wienchbenjamin anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants
AT kruschebenjamin anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants
AT tanepierre anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants
AT folefocgabrieln anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants
AT efferththomas anticanceractivitiesofsixselectednaturalcompoundsofsomecameroonianmedicinalplants